A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer
1. 请及时下载文件确认是否正确, 系统将在 2026-01-11 17:34:01 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.clbc.2024.11.019
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1526820924003331
其他信息:
出版社: Elsevier BV
作者: Sailaja Kamaraju; Amy M. Fowler; Sergey Tarima; Lubna N. Chaudhary; Mark E. Burkard; Thomas Giever; Yee C. Cheng; Amanda Parkes; Carol A. Lange; Michele Pipp-Dahm; Robert Hegeman; Nauman Siddiqui; Amy Stella; Saurabh Rajguru; Kyleigh Twaroski; Luke Zurbriggen; Julie M. Jorns; Hallgeir Rui; Quinton J. Keigley; Scott B. Perlman; Kelley Salem; Tyler J. Bradshaw; Tarek Sahmoud; Kari Wisinski
